O Bulbena

Author PubWeight™ 38.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993 1.61
2 Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997 1.59
3 Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy 2003 1.53
4 Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. Gastroenterology 1992 1.49
5 Cyclooxygenase and lipoxygenase metabolism in sodium taurocholate induced acute hemorrhagic pancreatitis in rats. Prostaglandins 1993 1.46
6 Altered levels of tissue and urinary prostacyclin in rats subjected to pancreas transplantation. Prostaglandins 1991 1.39
7 In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 2003 1.07
8 Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002 1.04
9 Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis. Thorax 2006 0.99
10 Oxidised lipids present in ascitic fluid interfere with the regulation of the macrophages during acute pancreatitis, promoting an exacerbation of the inflammatory response. Gut 2008 0.98
11 Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992 0.98
12 P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax 2002 0.89
13 Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis. Crit Care Med 2003 0.87
14 Zinc compounds, a new treatment in peptic ulcer. Drugs Exp Clin Res 1989 0.86
15 Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 2000 0.84
16 Differential activity of nitric oxide synthase in human nasal mucosa and polyps. Eur Respir J 1996 0.83
17 Xanthine oxidase activation in cerulein- and taurocholate-induced acute pancreatitis in rats. Arch Int Physiol Biochim Biophys 1995 0.83
18 Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci 1998 0.82
19 15-Hydroxyeicosatetraenoic acid as a major eicosanoid in nasal secretions: assay by high-performance liquid chromatographic-radioimmunoassay and gas chromatographic-mass spectrometric procedures. J Chromatogr 1989 0.81
20 Simultaneous reversed-phase extraction of lipoxygenase and cyclooxygenase metabolites of arachidonic acid in nasal secretions: methodological aspects. J Chromatogr 1990 0.81
21 In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. Prostaglandins 1991 0.80
22 Modern high-performance liquid chromatographic-radioimmunoassay strategies for the study of eicosanoids in biological samples. J Chromatogr 1989 0.80
23 Effects of omega-toxins on noradrenergic neurotransmission in beating guinea pig atria. Eur J Pharmacol 1995 0.80
24 Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol 1985 0.80
25 Permeation by zinc of bovine chromaffin cell calcium channels: relevance to secretion. Pflugers Arch 1994 0.79
26 Prostanoid generation in early stages of acute pancreatitis: a role for nitric oxide. Inflammation 1994 0.79
27 Anti-ulcer and membrane stabilizing actions of zinc acexamate. Arch Int Pharmacodyn Ther 1987 0.79
28 Thermospray liquid chromatography/mass spectrometry of prostaglandin methyl ester derivatives: application to the determination of prostaglandins E2 and D2 in rat gastric mucosa. Biomed Environ Mass Spectrom 1988 0.79
29 Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. Transplantation 1995 0.79
30 Constitutive nuclear factor-kappaB activity in human upper airway tissues and nasal epithelial cells. Eur Respir J 2000 0.78
31 Gastrotoxic activity and inhibitory effects on gastric mucosal PGE2 production with different non-steroidal anti-inflammatory drugs: modifications induced by pretreatment with zinc acexamate. Prostaglandins Leukot Essent Fatty Acids 1994 0.78
32 Zinc compounds as therapeutic agents in peptic ulcer. Methods Find Exp Clin Pharmacol 1989 0.78
33 Prostanoids and oxygen free radicals in early stages of experimental acute pancreatitis. Dig Dis Sci 1994 0.78
34 Effect of zinc acexamate and ranitidine on chronic gastric lesions in the rat. Digestion 1990 0.78
35 Effect of cold-restraint stress and zinc acexamate on gastric mucus production in intact glands. Arch Int Pharmacodyn Ther 1987 0.78
36 Macrophage activation in exacerbated COPD with and without community-acquired pneumonia. Eur Respir J 2009 0.78
37 N-phenyllinoleamide metabolism by human polymorphonuclear leukocytes. Xenobiotica 1994 0.77
38 Mass spectrometric identification of N-phenyllinoleamide metabolites in mouse peritoneal macrophages. Rapid Commun Mass Spectrom 1995 0.77
39 Cyclooxygenase and lipoxygenase arachidonate metabolites synthesized by mouse peritoneal macrophages: in vitro effect of N-phenyllinoleamide from toxic oil samples. Agents Actions 1993 0.77
40 Metabolism of N-phenyllinoleamide by rat liver. J Chromatogr 1993 0.77
41 Arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. J Lipid Mediat Cell Signal 1994 0.77
42 Effect of prostaglandins and superoxide dismutase administration on oxygen free radical production in experimental acute pancreatitis. Inflammation 1993 0.76
43 Cytoprotective and antisecretory activity of a ranitidine-zinc complex. Prostaglandins Leukot Essent Fatty Acids 1995 0.75
44 Urinary prostanoids excretion in kidney transplantation: its relationship to acute rejection and cyclosporine-induced nephrotoxicity. Transplant Proc 1994 0.75
45 Antiulcerogenic activity of zinc acexamate in different experimental models. Methods Find Exp Clin Pharmacol 1987 0.75
46 Pancreas lipoxygenase arachidonic acid metabolites production in streptozotocin-induced diabetes in rats. Horm Metab Res 1994 0.75
47 Recovery of nasal prostaglandin production after inhibition by aspirin. Prostaglandins Leukot Essent Fatty Acids 1990 0.75
48 Effects of zinc acexamate on gastric mucosal production of prostaglandin E2 in normal and stressed rats. Prostaglandins Leukot Essent Fatty Acids 1988 0.75
49 Effect of zinc acexamate on gastric lesions induced by aspirin: a morphological study. Eur J Pharmacol 1990 0.75
50 Gas chromatographic/mass spectrometric analysis of high-performance liquid chromatographic fractions reflecting arachidonic acid metabolism in mouse peritoneal macrophages. Biol Mass Spectrom 1992 0.75
51 [Comparison of various methods for the study of noradrenaline fixation to proteins]. Arch Farmacol Toxicol 1977 0.75
52 Relationship between gastric levels and antiulcerogenic activity of zinc. Arch Int Pharmacodyn Ther 1991 0.75
53 Transmucosal potential difference in experimental colitis in rats. Inflammation 1995 0.75
54 Application of liquid radiochromatographic techniques to the metabolic profiling of xenobiotically-mediated arachidonate metabolism. J Pharm Biomed Anal 1991 0.75
55 Prostaglandin E2 and thromboxane B2 levels in rats subjected to pancreas transplantation. Prostaglandins 1990 0.75
56 Gastrointestinal surface changes: interpretation problems and indexing possibilities (a review). Scanning Microsc 1989 0.75
57 [Nitric oxide synthase activity in nasal mucosa]. Acta Otorrinolaringol Esp 1998 0.75
58 Zinc acexamate reduces gastric damage induced by platelet-activating factor. Prostaglandins Leukot Essent Fatty Acids 1989 0.75
59 Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. Dig Dis Sci 1993 0.75
60 [Protection by zinc acexamate against gastric lesions induced by non-steroid anti-inflammatory agents]. Rev Esp Enferm Dig 1993 0.75
61 Cyclooxygenase products of metabolism of arachidonic acid in mouse macrophages exposed to N-phenyllinoleamide from toxic oil samples. Prostaglandins Leukot Essent Fatty Acids 1990 0.75
62 Calcium channel blockers in experimental acute pancreatitis: effect on tissue prostanoids and oxygen free radicals. Pancreas 1996 0.75
63 [NMR determination of the conformation of adrenaline in a complex with Mg2+ and ATP]. Arch Farmacol Toxicol 1979 0.75
64 Influence of N-phenyllinoleamide from toxic oil samples on the lipoxygenase metabolism of exogenous arachidonic acid in mouse peritoneal macrophages. Prostaglandins Leukot Essent Fatty Acids 1992 0.75
65 Morphological study of gastric lesions developing in the rat under several damaging conditions: modifications induced by pretreatment with zinc acexamate. Scanning Microsc 1992 0.75
66 Prostaglandin PGE2 and PGF2alpha levels in nasal secretions from healthy subjects by liquid chromatography and radioimmunological assay. J Pharm Biomed Anal 1988 0.75
67 [Effects of zinc acexamate on blood flow in the gastric mucosa of the rat]. Rev Esp Enferm Apar Dig 1988 0.75
68 Prostaglandin levels in infertile patients affected by asthenozoospermia and prostatitis. Prostaglandins Leukot Essent Fatty Acids 1988 0.75
69 Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatics. Adv Prostaglandin Thromboxane Leukot Res 1991 0.75
70 Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. Transplantation 1994 0.75
71 Application of totally automated on-line sample clean up system for extraction and high-performance liquid chromatography separation of peptide leukotrienes. J Pharm Biomed Anal 1994 0.75
72 Determination of oxidation products of N-phenyllinoleamide: Spanish toxic oil syndrome studies. J Chromatogr 1988 0.75
73 Oxidative metabolism of N-phenyllinoleamide by human nasal polyps. Prostaglandins 1992 0.75
74 Pancreas prostanoid production in ischemia and reperfusion. Prostaglandins 1992 0.75
75 [Variations in the conformation of adrenaline as a function of pH]. Arch Farmacol Toxicol 1979 0.75
76 Induction of c-fos messenger RNA by 3-(N-phenylamino)-1,2-propanediol esters, compounds related to Toxic Oil Syndrome. Chem Biol Interact 2004 0.75
77 [1H NMR study of the conformation of adrenaline in the presence of Na+ and K+ ions]. Arch Farmacol Toxicol 1979 0.75